Bio Essence Corp financial data

Symbol
BIOE on OTC
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8% % -69%
Debt-to-equity -108% % 46%
Return On Equity 5% % -93%
Return On Assets -68% % 9.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38,009,000 shares 0%
Common Stock, Shares, Outstanding 38,009,000 shares 0%
Entity Public Float $26,844,590 USD
Common Stock, Value, Issued $3,801 USD 0%
Weighted Average Number of Shares Outstanding, Basic 38,009,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 38,009,000 shares 9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $136,800 USD 1.6%
Cost of Revenue $41,040 USD -24%
General and Administrative Expense $516,462 USD -33%
Operating Income (Loss) $125,765 USD 81%
Nonoperating Income (Expense) $33,889 USD 97%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $159,654 USD 91%
Income Tax Expense (Benefit) $800 USD 0%
Net Income (Loss) Attributable to Parent $160,453 USD 89%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $28,741 USD -3.6%
Accounts Receivable, after Allowance for Credit Loss, Current $4,969 USD -92%
Assets, Current $184,378 USD -74%
Operating Lease, Right-of-Use Asset $1,178,577 USD 21%
Intangible Assets, Net (Excluding Goodwill) $156 USD -60%
Other Assets, Noncurrent $274 USD -99%
Assets $184,534 USD -74%
Accounts Payable, Current $10,608 USD -67%
Liabilities, Current $3,230,021 USD 5.3%
Operating Lease, Liability, Noncurrent $99,668 USD -85%
Other Liabilities, Noncurrent $301,959 USD 438%
Liabilities $3,286,514 USD -10%
Retained Earnings (Accumulated Deficit) $10,582,160 USD -1.5%
Stockholders' Equity Attributable to Parent $3,101,980 USD -5.5%
Liabilities and Equity $184,534 USD -74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $26,069 USD 85%
Net Cash Provided by (Used in) Financing Activities $24,698 USD -86%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 38,009,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $23 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28,741 USD -3.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities $543 USD -88%
Deferred Tax Assets, Valuation Allowance $1,326,082 USD 103%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $699,042 USD 12%
Operating Lease, Liability $1,394,037 USD
Depreciation $238 USD
Property, Plant and Equipment, Gross $56,505 USD 0%
Operating Lease, Liability, Current $1,496,907 USD 64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $1,325,904 USD
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $7,476,379 USD 0%
Amortization of Intangible Assets $58 USD -75%
Depreciation, Depletion and Amortization $497 USD -80%
Interest Expense $542 USD -2.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%